These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 20427525)

  • 1. Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets.
    Wang W; Lu B; Zhou H; Suguitan AL; Cheng X; Subbarao K; Kemble G; Jin H
    J Virol; 2010 Jul; 84(13):6570-7. PubMed ID: 20427525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza H1N1 A/Solomon Island/3/06 virus receptor binding specificity correlates with virus pathogenicity, antigenicity, and immunogenicity in ferrets.
    Xu Q; Wang W; Cheng X; Zengel J; Jin H
    J Virol; 2010 May; 84(10):4936-45. PubMed ID: 20200248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets.
    Suguitan AL; Cheng X; Wang W; Wang S; Jin H; Lu S
    PLoS One; 2011; 6(7):e21942. PubMed ID: 21760928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hemagglutinin protein of influenza A/Vietnam/1203/2004 (H5N1) contributes to hyperinduction of proinflammatory cytokines in human epithelial cells.
    Cheng X; Xu Q; Song E; Yang CF; Kemble G; Jin H
    Virology; 2010 Oct; 406(1):28-36. PubMed ID: 20667571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
    Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity.
    Chutinimitkul S; van Riel D; Munster VJ; van den Brand JM; Rimmelzwaan GF; Kuiken T; Osterhaus AD; Fouchier RA; de Wit E
    J Virol; 2010 Jul; 84(13):6825-33. PubMed ID: 20392847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines.
    Cheng X; Eisenbraun M; Xu Q; Zhou H; Kulkarni D; Subbarao K; Kemble G; Jin H
    PLoS One; 2009; 4(2):e4436. PubMed ID: 19209231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemagglutinin glycosylation modulates the pathogenicity and antigenicity of the H5N1 avian influenza virus.
    Zhang X; Chen S; Jiang Y; Huang K; Huang J; Yang D; Zhu J; Zhu Y; Shi S; Peng D; Liu X
    Vet Microbiol; 2015 Feb; 175(2-4):244-56. PubMed ID: 25544041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H5N1 influenza A virus with K193E and G225E double mutations in haemagglutinin is attenuated and immunogenic in mice.
    Han PF; Li J; Hu Y; Sun W; Zhang S; Yang YH; Li YC; Kang XP; Wu XY; Zhu SY; Zhang Y; Zhu QY; Qin CF; Jiang T
    J Gen Virol; 2015 Sep; 96(9):2522-2530. PubMed ID: 25998916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in haemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and may contribute to transmissibility.
    Shelton H; Roberts KL; Molesti E; Temperton N; Barclay WS
    J Gen Virol; 2013 Jun; 94(Pt 6):1220-1229. PubMed ID: 23486663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase.
    Tsai C; Caillet C; Hu H; Zhou F; Ding H; Zhang G; Zhou B; Wang S; Lu S; Buchy P; Deubel V; Vogel FR; Zhou P
    Vaccine; 2009 Nov; 27(48):6777-90. PubMed ID: 19732860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets.
    Chen Z; Zhou H; Kim L; Jin H
    J Virol; 2012 Mar; 86(5):2780-6. PubMed ID: 22190726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets.
    Forrest HL; Khalenkov AM; Govorkova EA; Kim JK; Del Giudice G; Webster RG
    Vaccine; 2009 Jun; 27(31):4187-95. PubMed ID: 19406182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased acid stability of the hemagglutinin protein enhances H5N1 influenza virus growth in the upper respiratory tract but is insufficient for transmission in ferrets.
    Zaraket H; Bridges OA; Duan S; Baranovich T; Yoon SW; Reed ML; Salomon R; Webby RJ; Webster RG; Russell CJ
    J Virol; 2013 Sep; 87(17):9911-22. PubMed ID: 23824818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.
    Suguitan AL; McAuliffe J; Mills KL; Jin H; Duke G; Lu B; Luke CJ; Murphy B; Swayne DE; Kemble G; Subbarao K
    PLoS Med; 2006 Sep; 3(9):e360. PubMed ID: 16968127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies.
    Verma S; Dimitrova M; Munjal A; Fontana J; Crevar CJ; Carter DM; Ross TM; Khurana S; Golding H
    J Virol; 2012 Nov; 86(22):12283-93. PubMed ID: 22951833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broadening the H5N3 Vaccine Immunogenicity against H5N1 Virus by Modification of Neutralizing Epitopes.
    Rajesh Kumar S; Chelvaretnam S; Tan Y; Prabakaran M
    Viruses; 2017 Dec; 10(1):. PubMed ID: 29295514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of human-type receptor binding specificity by new H5N1 influenza virus sublineages during their emergence in birds in Egypt.
    Watanabe Y; Ibrahim MS; Ellakany HF; Kawashita N; Mizuike R; Hiramatsu H; Sriwilaijaroen N; Takagi T; Suzuki Y; Ikuta K
    PLoS Pathog; 2011 May; 7(5):e1002068. PubMed ID: 21637809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.